medigraphic.com
Boletín Clínico de la Asociación Médica del Hospital Infantil del Estado de Sonora

2022, Number 2

<< Back Next >>

Bol Clin Hosp Infant Edo Son 2022; 39 (2)

Support for quality of life in patients with osteosarcoma. Experience of the pediatric palliative care department

Castañeda RSA, Barrientos DA, Reyes LMC, Garduño EA

Language: Spanish
References: 18
Page: 25-31
PDF size: 253.48 Kb.


ABSTRACT

Osteosarcoma is the most common bone tumor in childhood ranking sixth in frequency; it is extremely aggressive and survival in Mexico is low. It causes complex symptoms that deteriorate the quality of life. Previously palliative care focused on end-of-life care, now it begins diagnosis by improving adherence to treatment, improving symptoms and directly increasing survival. Given this reality, the objective of this study involved the description of the characteristics of pediatric patients with osteosarcoma who have been seen in the quality of life support department. The design was retrospective and descriptive. Through the diagnostic record of the clinical archive, the records of patients with osteosarcoma were obtained. We included 36 cases, distribution by sex H:M, 60:40, with a mean age of 12 years. Pain (77.7%) and dyspnea (47.2%) were the most frequent clinical manifestations. 38.8% of patients were referred to a curative phase of the disease; 30.5% in incurable stage with poor quality of life. Regarding survival, only 1 patient is still alive (2.7%). The results are consistent with other studies in national and international hospitals. Pain and dyspnea are the most frequent clinical manifestations, so identifying and treating them is a priority. The use of opioids is warranted for the symptomatic management of patients with osteosarcoma. Quality of life support services need to be included in the initial care of all patients diagnosed with cancer.


REFERENCES

  1. Sung H, Ferlay J, Siegel RL, Laversanne M, SoerjomataramI, Jemal A, Bray F. Global Cancer Statistics 2020: GLOBOCAN Estimates of Incidenceand Mortality Worldwide for 36 Cancers in 185Countries. CA Cancer J Clin. 2021 May; 71(3): 209-249. doi: 10.3322/caac.21660 Epub [2021, Feb. 4].PMID: 33538338

  2. Dirección General de Epidemiología. Registro deCáncer en Niños y Adolescentes. [En línea].Ciudadde México. [Citado 1 de junio de 2020]. Disponibleen: https://www.gob.mx/salud%7Ccensia/articulos/cancer-infantil-en-mexico-130956

  3. Gupta S, Howard SC, Hunger SP, et al. TreatingChildhood Cancer in Low- and Middle-IncomeCountries. En: Gelband H, Jha P, SankaranarayananR, et al., editors. Cancer: Disease ControlPriorities, Third Edition (Volume 3). Washington(DC): The International Bank for Reconstructionand Development / The World Bank; 2015, Nov. 1.Chapter 7. Disponible en: https://www.ncbi.nlm.nih.gov/books/NBK343626/ doi: 10.1596/978-1- 4648-0349-9_ch7

  4. Howard SC, Zaidi A, Cao X, Weil O, Bey P, Patte C, etal. The My Child Matters programme: effect of public-private partnerships on paediatric cancer carein low-income and middle-income countries. LancetOncol. 2018; 19(5): e252-e266. doi: 10.1016/S1470-2045(18)30123-2 PMID: 29726390

  5. Wu PK, Chen WM, Chen CF, Lee OK, Haung CK,Chen TH. Primary osteogenic sarcoma with pulmonarymetastasis: clinical results and prognosticfactors in 91 patients. Jpn J Clin Oncol. 2009;39(8), 514-522.

  6. Escamilla-Santiago RA, Narro-Robles J, Fajardo-Gutiérrez A, Rascón-Pacheco RA, López-CervantesM. Tendencia de la mortalidad por cánceren niños y adolescentes según grado de marginaciónen México (1990-2009). Salud Pública de México.2012; 54(6): 587-594.

  7. Rainusso N, Wang L, Yustein JT. The Adolescentand Young Adult With Cancer: State of the Art -Bone Tumors. Curr Oncol Rep. 2013; 15: 296-307.

  8. Federman N, Bernthal N, Eilber FC, William DTap. The Multidisciplinary Management of Osteosarcoma.C urr Treat O ptions i n O ncol. 2 009;10: 82-93. Disponible en: https://doi.org/10.1007/s11864-009-0087-3

  9. Castellanos-Toledo A. Osteosarcoma en el Adolescentey en el Adulto Joven. En Osteosarcoma.México D.F: Editorial Alfil; 2014: 65-90.

  10. Durnali A, Alkis N, Cangur S, Yukruk FA, Inal A,Tokluoglu S, et al. Prognostic factors for teenageand adult patients with high-grade osteosarcoma:an analysis of 240 patients. Med Oncol. 2013;30(3): 624. doi: 10.1007/s12032-013-0624-6 Epub[2013, Jun. 9]. PMID: 23749307

  11. Weaver MS, Heinze KE, Kelly KP, Wiener L, CaseyRL, Bell CJ, et al. Palliative Care as a Standard ofCare in Pediatric Oncology. Pediatr Blood Cancer.2015; 62 Suppl 5(Suppl 5): S829-33. doi: 10.1002/pbc.25695 PMID: 26700928; PMCID: PMC5198905

  12. Garduño EA, Velasco PG, Jon TR, Reyes LM, OlivaresDC. Modelo de atención de la unidad de cuidadospaliativos. En Cuidados Paliativos Pediátricos[2.a Ed.]. Ciudad de México: Trillas; 2018: 21-43.

  13. World Health Organization. Cure All framework:WHO global initiative for childhood cancer: increasingaccess, advancing quality, saving lives. WorldHealth Organization. [En línea]. Disponible en: https://apps.who.int/iris/handle/10665/347370 Licencia:CC BY-NC-SA 3.0 IGO

  14. Garduño EA, Tobie GW, Reyes LM, Córdoba NM,Cervantes BM, Jon TR. Aspectos médicos. EnGuía práctica para la atención integral a niños encuidados paliativos. Ciudad de México: Corinter;2019: 2-26.

  15. Lansky SB, List MA, Lansky LL, Ritter‐Sterr C, MillerDR. The measurement of performance in childhoodcancer patients. Cancer. 1987; 60(7): 1651-1656.

  16. Downing J, Jassal SS, Mathews L, Brits H, Friedrichsdorf SJ. Pediatric pain management in palliativecare. Pain Manag. 2015; 5(1): 23-35. doi:10.2217/pmt.14.45 PMID: 25537696

  17. Palomo-Colli MÁ, Peña del Castillo H, Juárez VillegasLE, Lezama del Valle P, Cortés-RodríguezR, Zapata-Tarrés M. Resultados del tratamientode niños con osteosarcoma en el Hospital Infantilde México “Federico Gómez”. GAMO. 2001; 11(5):306-309.

  18. Belayneh R, Fourman MS, Bhogal S, Weiss KR.Update on Osteosarcoma. Curr Oncol Rep. 2021,Abril 21; 23(6): 71. doi: 10.1007/s11912-021-01053-7 PMID: 33880674 Fuente: citado en Martino, modificadopor Garduño (2018).




2020     |     www.medigraphic.com